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Introduction
Proteinuria is a common fi nding during the clinical out-
come of thermally injured patients [1]. It has long been 
known that proteinuria appears shortly after severe 
burns, and is detectable for several weeks until patients 
become critically ill [2]. Proteinuria quantitatively varies 
from 0.5 to 3 to 4 g/day [2,3]. From a nephrological point 
of view, however, proteinuria accompanying severe burns 
is still an intriguing factor due to its entity and duration. 
We still have no exhaustive understanding of its clinical 
signifi cance and role, mainly because of a lack of data on 
its pathogenesis.
Studies using SDS polyacrylamide gel electrophoresis 
performed in the early 1980s demonstrated that the 
initial pattern of proteinuria is of mixed type, indicating a 
lesion of both glomerulus and tubule [2]. Th en, after a 
week, the protein excretion pattern gradually changes to 
typical tubular proteinuria, and persists like this for 
several weeks [2]. Usually its duration and amount refl ect 
the severity of burns: more severe burns lead to more 
proteinuria and worse patient outcome [2,3].
Proteinuria and clinical outcome in 
burn patients
In the past 10  years many reports have focused on the 
relationship between severe burns, acute kidney injury 
(AKI; staged using RIFLE or AKI classifi cation) and 
proteinuria. Th ese studies demonstrated a high incidence 
of AKI in burn patients, an association of AKI with 
dysfunction of other organs, a pathogenetic role of sepsis 
in AKI and, in particular, a direct correlation between 
AKI and mortality [4,5].
Th e study of Hu and coworkers [1] in the previous issue 
of Critical Care provides additional evidence on the 
clinical relevance of proteinuria on the outcome of burn 
patients. It explores in a large cohort of 369 severe burn 
patients (total burned surface area >30%) the determi-
nants of proteinuria, and its infl uence on AKI staged 
according to the RIFLE classifi cation and on clinical 
outcome. Proteinuria, evaluated as positive urine dipstick 
readings, was absent in 31.5% of patients, mild (5 to 
20  mg/dl) in 45.5% and heavy (>100  mg/dl) in 23%. 
Patients with proteinuria were older, with a higher inci-
dence of inhalation injury, more severe burns and more 
incidence of sepsis (67%) than in patients with mild (46%) 
or absent (15%) proteinuria. In addition, proteinuric 
patients were more prone to develop AKI (incidence of 
55%). In contrast, none of the patients without protein-
uria developed AKI, suggesting that the persistent absence 
of proteinuria excludes the development of AKI. Th e 
mortality rate of patients with AKI was 29%, signifi cantly 
higher than that observed in patients without AKI 
(12.50%). Finally, patients with proteinuria had signifi -
cantly longer mechanical ventilation durations, longer 
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ICU stays, and higher mortality rates (30.8%) than 
patients with mild (16.7%) or absent (0.8%) proteinuria.
Pathogenesis of proteinuria in burn patients
Proteinuria in thermally injured patients is considered 
the mirror of increased systemic capillary permeability 
[6]. However, proteinuria (or preferably proteinuria/
creatininuria ratio to correct for variation of urinary fl ow 
rate) is possibly a direct marker of renal injury. In fact, it 
has been demonstrated that proteinuria negatively corre-
lates with both decreased creatinine and urea clearance 
as an index of loss of glomerular function and positively 
correlates with both Na+ and K+ fraction excretion 
refl ecting loss of tubular function [7]. A plethora of 
infl ammatory mediators (cyto kines, polypeptides, lipid 
mediators) targeting endothelial cells have been impli-
cated in glomerular and peritubular capillary dysfunction 
[8]. Indeed, the plasma of burn patients contains pro-
apoptotic factors at levels refl ecting the presence of sepsis 
and AKI [7]. Th ese circulating pro-apoptotic factors 
reduce the viability and function of tubular cells and 
podocytes by a mechanism dependent on up-regulation 
of pro-infl ammatory and pro-apoptotic genes and down-
regulation of apoptosis inhibitors. More over, they alter 
permeability by disrupting tight junctions and the 
polarity of tubular cells and by inducing nephrin loss in 
podocytes [7]. Th erefore, proteinuria refl ects a direct 
negative infl uence of plasma factors on renal paren chy-
mal cells and requires further studies on new extra cor-
poreal therapeutic approaches in burn patients [9-11].
In conclusion, the study of Hu and colleagues reminds 
us that proteinuria in burn patients should receive due 
consideration.
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